T. Veerabasappa Gowda

1.9k total citations
59 papers, 1.6k citations indexed

About

T. Veerabasappa Gowda is a scholar working on Genetics, Molecular Biology and Pharmacology. According to data from OpenAlex, T. Veerabasappa Gowda has authored 59 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Genetics, 34 papers in Molecular Biology and 32 papers in Pharmacology. Recurrent topics in T. Veerabasappa Gowda's work include Venomous Animal Envenomation and Studies (49 papers), Healthcare and Venom Research (30 papers) and Ion channel regulation and function (22 papers). T. Veerabasappa Gowda is often cited by papers focused on Venomous Animal Envenomation and Studies (49 papers), Healthcare and Venom Research (30 papers) and Ion channel regulation and function (22 papers). T. Veerabasappa Gowda collaborates with scholars based in India, United States and Switzerland. T. Veerabasappa Gowda's co-authors include Bannikuppe S. Vishwanath, R. Manjunatha Kini, S.R. Kasturi, Kesturu S. Girish, Kempaiah Kemparaju, Deepa Machiah, S. Nagaraju, Rangaiah Shashidharamurthy, Balapal S. Basavarajappa and A. G. Appu Rao and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Molecular Biology and Journal of Chromatography A.

In The Last Decade

T. Veerabasappa Gowda

56 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Veerabasappa Gowda India 22 1.3k 881 451 318 274 59 1.6k
Eleonora Condrea Israel 22 1.2k 1.0× 1.0k 1.2× 589 1.3× 70 0.2× 139 0.5× 47 1.6k
Chen-Chung Yang Taiwan 18 889 0.7× 792 0.9× 428 0.9× 49 0.2× 101 0.4× 50 1.1k
Robert Frangež Slovenia 19 134 0.1× 357 0.4× 240 0.5× 28 0.1× 91 0.3× 76 940
Ralph SCHALOSKE Germany 11 228 0.2× 592 0.7× 88 0.2× 36 0.1× 44 0.2× 14 967
Subir Chandra Dasgupta India 14 272 0.2× 315 0.4× 126 0.3× 35 0.1× 38 0.1× 51 656
Ana Oliveira Portugal 15 227 0.2× 319 0.4× 102 0.2× 55 0.2× 35 0.1× 25 552
W.B. Elliott United States 22 233 0.2× 626 0.7× 345 0.8× 21 0.1× 15 0.1× 78 1.3k
Olga B. Henriques Brazil 13 235 0.2× 284 0.3× 100 0.2× 31 0.1× 14 0.1× 31 554
Emmanuel Zazopoulos United States 19 414 0.3× 1.3k 1.4× 1.0k 2.2× 160 0.5× 2 0.0× 26 2.0k
Stanka Stoeva Germany 21 169 0.1× 568 0.6× 60 0.1× 19 0.1× 29 0.1× 56 1.2k

Countries citing papers authored by T. Veerabasappa Gowda

Since Specialization
Citations

This map shows the geographic impact of T. Veerabasappa Gowda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Veerabasappa Gowda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Veerabasappa Gowda more than expected).

Fields of papers citing papers by T. Veerabasappa Gowda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Veerabasappa Gowda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Veerabasappa Gowda. The network helps show where T. Veerabasappa Gowda may publish in the future.

Co-authorship network of co-authors of T. Veerabasappa Gowda

This figure shows the co-authorship network connecting the top 25 collaborators of T. Veerabasappa Gowda. A scholar is included among the top collaborators of T. Veerabasappa Gowda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Veerabasappa Gowda. T. Veerabasappa Gowda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basavarajappa, Balapal S., et al.. (2014). Biochemical and pharmacological characterization of three toxic phospholipase A2s from Daboia russelii snake venom. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 168. 28–38. 10 indexed citations
2.
Manjunath, Yariswamy, et al.. (2013). Implications of phytochemicals in snakebite management: present status and future prospective. Toxin Reviews. 33(3). 60–83. 25 indexed citations
3.
Gowda, T. Veerabasappa, et al.. (2010). Sunflower (Helianthus annuus L.) petals: A new biological source of Lutein. Research Journal of Pharmaceutical Biological and Chemical Sciences. 1(4). 438–448. 4 indexed citations
4.
5.
Kumar, Anoop & T. Veerabasappa Gowda. (2006). Novel non-enzymatic toxic peptide of Daboia russelii (Eastern region) venom renders commercial polyvalent antivenom ineffective. Toxicon. 47(4). 398–408. 16 indexed citations
6.
Machiah, Deepa & T. Veerabasappa Gowda. (2006). Purification of a post-synaptic neurotoxic phospholipase A2 from Naja naja venom and its inhibition by a glycoprotein from Withania somnifera. Biochimie. 88(6). 701–710. 31 indexed citations
7.
Nagaraju, S., Deepa Machiah, Kempaiah Kemparaju, et al.. (2006). The anti‐snake venom properties of Tamarindus indica (leguminosae) seed extract. Phytotherapy Research. 20(10). 851–858. 73 indexed citations
8.
Machiah, Deepa, Kesturu S. Girish, & T. Veerabasappa Gowda. (2006). A glycoprotein from a folk medicinal plant, Withania somnifera, inhibits hyaluronidase activity of snake venoms. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 143(2). 158–161. 51 indexed citations
9.
Frey, Brigitte M., et al.. (2005). Inhibition of secretory phospholipase A2 enzyme by bilirubin: A new role as endogenous anti-inflammatory molecule. Molecular and Cellular Biochemistry. 276(1-2). 219–225. 20 indexed citations
10.
Krishnakantha, T. P., et al.. (2004). Purification of a Class B1 platelet aggregation inhibitor phospholipase A2 from Indian cobra (Naja Naja) venom. Biochimie. 86(3). 203–210. 15 indexed citations
11.
Gowda, T. Veerabasappa, et al.. (1998). Isolation and characterization of an endogenous inhibitor of phospholipase A2 from Indian cobra (Naja naja naja) venom. Toxicon. 36(4). 639–644. 1 indexed citations
12.
Gowda, T. Veerabasappa, et al.. (1998). Purification and characterization of three acidic, cytotoxic phospholipases A2 from Indian cobra (Naja naja naja) venom. Toxicon. 36(6). 921–932. 43 indexed citations
14.
Basavarajappa, Balapal S., et al.. (1993). Immunochemical cross-reactivity of neurotoxic phospholipase A2 enzymes from Indian cobra (Naja naja naja) venom using polyclonal antibodies. Toxicon. 31(9). 1167–1177. 7 indexed citations
15.
Gowda, T. Veerabasappa & John L. Middlebrook. (1993). Effects of myonecrotic snake venom phospholipase A2 toxins on cultured muscle cells. Toxicon. 31(10). 1267–1278. 19 indexed citations
16.
Gowda, T. Veerabasappa, et al.. (1991). Purification and characterization of a neurotoxic phospholipase A2 from Indian cobra (Naja naja naja) venom. Toxicon. 29(11). 1345–1349. 21 indexed citations
18.
Vishwanath, Bannikuppe S., R. Manjunatha Kini, & T. Veerabasappa Gowda. (1988). Purification and partial biochemical characterization of an edema inducing phospholipase A2 from Vipera russelli (Russell's viper) snake venom. Toxicon. 26(8). 713–720. 51 indexed citations
19.
Vishwanath, Bannikuppe S., A. G. Appu Rao, & T. Veerabasappa Gowda. (1987). Interaction of phospholipase A2 from Vipera russelli venom with aristolochic acid: A circular dichroism study. Toxicon. 25(9). 939–946. 54 indexed citations
20.
Kini, R. Manjunatha & T. Veerabasappa Gowda. (1984). Rapid method for separation and purification of four isoenzymes of phosphodiesterase from trimeresurus flavoviridis (habu snake) venom. Journal of Chromatography A. 291. 299–305. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026